SCHEMBL8958798

SCHEMBL8958798

C[Si](C)(C)Oc1nccc(Cl)n1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.33
RXRA P19793 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2B Q13224 1/20 0.30
RPS6KA5 O75582 1/20 0.30
RPS6KA4 O75676 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61938 0.78
SCHEMBL5111507 0.78 SCN9A (0.44) SCN9ARXRAGRIN1GRIN2BRPS6KA5
SCHEMBL10017439 0.77 EDNRB (0.37) RXRAGRIN1GRIN2B
SCHEMBL1376899 0.77 NUDT1 (0.32)
SCHEMBL7029492 0.75 POLB (0.42) RXRAGRIN1GRIN2B
SCHEMBL10048540 0.75 SCN9A (0.47) SCN9ARXRAGRIN1GRIN2B
SCHEMBL19073173 0.75 NOS3 (0.31)
SCHEMBL3513367 0.75 RXRA (0.33) SCN9ARXRAGRIN1GRIN2B
SCHEMBL12701660 0.73 LRRK2 (0.37) SCN9ARXRAGRIN1GRIN2BRPS6KA5
SCHEMBL1475163 0.73 GAA (0.42) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0691981-A1 TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES THE WELLCOME FOUNDATION LIMITED (GB) 1996-01-17 EP disclosed
WO-1994020523-A1 TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-15 WO disclosed